Functional dyspepsia (FD) is a frequent disorder of gut-brain interaction, affecting 5–7% of people globally, with significant impairment in quality of life. The management of FD is challenging due to the lack of specific therapeutic approaches. Although food seems to play a role in symptom production, its pathophysiologic role in patients with FD is not fully understood. Most FD patients report that their symptoms are triggered by food, especially in the post-prandial distress syndrome (PDS) group, although evidence to support the use of dietary interventions are limited. FODMAPs can increase production of gas in the intestinal lumen, through fermentation by intestinal bacteria, can exert osmotic effects by increasing water volume and can cause an excessive production of short-chain fatty acids (propionate, butyrate, and acetate). Emerging scientific evidence, confirmed by recent clinical trials, suggest that FODMAPs could be involved in the pathogenesis of FD. Given the consolidated approach of the Low-FODMAP Diet (LFD) in irritable bowel syndrome (IBS) management and emerging scientific evidence regarding the LFD in FD, a therapeutic role of this diet may be hypothesized also in FD, either alone or in combination with other therapies.

Role of Low-FODMAP diet in functional dyspepsia: “Why”, “When”, and “to Whom”

Rettura F.;Lambiase C.;Grosso A.;Rossi A.;Tedeschi R.;Bellini M.
Ultimo
2023-01-01

Abstract

Functional dyspepsia (FD) is a frequent disorder of gut-brain interaction, affecting 5–7% of people globally, with significant impairment in quality of life. The management of FD is challenging due to the lack of specific therapeutic approaches. Although food seems to play a role in symptom production, its pathophysiologic role in patients with FD is not fully understood. Most FD patients report that their symptoms are triggered by food, especially in the post-prandial distress syndrome (PDS) group, although evidence to support the use of dietary interventions are limited. FODMAPs can increase production of gas in the intestinal lumen, through fermentation by intestinal bacteria, can exert osmotic effects by increasing water volume and can cause an excessive production of short-chain fatty acids (propionate, butyrate, and acetate). Emerging scientific evidence, confirmed by recent clinical trials, suggest that FODMAPs could be involved in the pathogenesis of FD. Given the consolidated approach of the Low-FODMAP Diet (LFD) in irritable bowel syndrome (IBS) management and emerging scientific evidence regarding the LFD in FD, a therapeutic role of this diet may be hypothesized also in FD, either alone or in combination with other therapies.
2023
Rettura, F.; Lambiase, C.; Grosso, A.; Rossi, A.; Tedeschi, R.; Ceccarelli, L.; Bellini, M.
File in questo prodotto:
File Dimensione Formato  
LFD Dyspepsia in press.pdf

non disponibili

Tipologia: Documento in Pre-print
Licenza: NON PUBBLICO - accesso privato/ristretto
Dimensione 968.34 kB
Formato Adobe PDF
968.34 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
1-s2.0-S1521691823000094-main.pdf

accesso aperto

Tipologia: Versione finale editoriale
Licenza: Creative commons
Dimensione 976.77 kB
Formato Adobe PDF
976.77 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11568/1176267
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 2
  • ???jsp.display-item.citation.isi??? ND
social impact